WO2010148394A1 - Herbal supplement - Google Patents
Herbal supplement Download PDFInfo
- Publication number
- WO2010148394A1 WO2010148394A1 PCT/US2010/039345 US2010039345W WO2010148394A1 WO 2010148394 A1 WO2010148394 A1 WO 2010148394A1 US 2010039345 W US2010039345 W US 2010039345W WO 2010148394 A1 WO2010148394 A1 WO 2010148394A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extracts
- herbal supplement
- cordyceps sinensis
- cinnamomum cassia
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
Definitions
- the present invention relates to natural herbal supplements for enhancing energy and/or sexual potency, and in particular to certain combinations of natural agents that include, for example, eucommia ulmoides, cynomorium songaricum, morinda officinalis, panax ginseng, and/or epimedium brevicornum.
- Hong Jing Tian in (Rhodiola rosea) has been recognized as an adaptogen - - a substance that non-specif ⁇ cally increases the resistance of an organism and does not disturb normal biological parameters.
- Hong Jin Tian has been cited in scientific articles for its adaptogenic, anti-stress, neuroendocrine, cardio-protective, antioxidant and anti-carcinogenic effects while bringing support to sexual functions.
- Prescription erectile dysfunction products are based upon inhibiting an enzyme in the body called phosphodi-esterase (PDE-5).
- PDE-5 phosphodi-esterase
- NO Nitrous Oxide
- cGMP second messenger
- PDE-5 By inhibiting this enzyme (PDE-5), prescription products prolong the effect of cGMP allowing more blood to flow into the caverns of the penis. Because other blood vessels of the body may be similarly affected, these products may be contraindicated for patients with the following underlying conditions:
- the invention provides an herbal supplement in the form of an aqueous elixer comprising extracts of at least three (and sometimes all four) agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum, morinda officinalis, and epimedium brevicornum.
- the invention provides an herbal supplement in the form of an aqueous elixer comprising extracts of at least four (and sometimes all five) agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum, morinda officinalis, panax ginseng and epimedium brevicornum.
- the invention provides an herbal supplement in the form of an aqueous elixer comprising extracts of epimedium brevicornum and of at least two additional agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum and morinda officinalis.
- each of the foregoing embodiments may further include extracts of at least two (and sometimes all three) agents selected from the group consisting of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
- the multiple ingredients present in the formulations of the invention are expected to provide a focused synergistic effect on a man's sexual response and at the same time provide overall energy to sustain this response.
- the experience gathered over many years for most of the ingredients discussed herein creates an expectation of a good safety profile.
- extracts of epimedium are utilized. Without intending to be bound by theory, it is believed that epimedium provides benefits via modulation of Cortisol levels (a primary stress hormone). Under conditions of high physical stress, the increased Cortisol levels are believed to cause fatigue and depress sex drive. Thus, bringing Cortisol levels back into normal ranges is also believed to help restore normal metabolism, energy levels and libido.
- Cortisol levels a primary stress hormone
- kidney energy and function may improve sexual stamina and performance while restoring vitality, energy and endurance.
- Some of the highly enriched ingredients of the present invention include agents which may be implicated in the maintenance of kidney health, thereby improving erections and strengthening and enhancing sexual functions in healthy males by a kidney-mediated mechanism, and may reduce symptoms for those who experience temporary or long term sexual dysfunction caused by stress, environmental or medical conditions.
- Siberian Ginseng, Codonopsis and Red Ginseng when used, is expected to provide the body with increased vitality and endurance important for sexual stamina.
- These longevity and energy herbs are believed to strengthen the system and be restorative to the body, helping to increase its efficiency. As a result they may help to direct more blood to the genitals and other erotically stimulated zones.
- a preferred all- natural herbal supplement of the invention is manufactured in a GMP compliant facility. Manufacturing begins by admixing the ingredients set forth below in the relative amounts set forth in the last column below. Thereafter the ingredients undergo extraction and preparation into an elixer in accordance with the technique set forth infra.
- Recommended daily dosage of the foregoing elixer is between 6 and 18 milliliters, e,g. about 10 milliliters.
Abstract
Natural herbal supplements are provided for enhancing energy and/or sexual potency. Combinations of natural agents include, for example, eucommia ulmoides, cynomorium songaricum, morinda officinalis, panax ginseng, and/or epimedium brevicornum. Some embodiments include cinnamomum cassia, cordyceps sinensis and/or foeniculum vulgare.
Description
HERBAL SUPPLEMENT
CROSS REFERENCE TQ RELATED APPLICATION(S1
The present application claims priority of U.S. Provisional Application No. 61/218,819 filed June 19, 2009, the contents of which are all incorporated herein by reference.
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to natural herbal supplements for enhancing energy and/or sexual potency, and in particular to certain combinations of natural agents that include, for example, eucommia ulmoides, cynomorium songaricum, morinda officinalis, panax ginseng, and/or epimedium brevicornum.
Description of the Related Art
Various herbs have long been used by various cultures, for example in traditional Chinese Medicine techniques that date back for centuries. For example, Epimidium brevicornum has been recommended for relieving fatigue, boosting sex drive (libido), increasing energy levels and enhancing recovery from strenuous exercise.
Hong Jing Tian in (Rhodiola rosea) has been recognized as an adaptogen - - a substance that non-specifϊcally increases the resistance of an organism and does not disturb normal biological parameters. Hong Jin Tian has been cited in scientific articles for its adaptogenic, anti-stress, neuroendocrine, cardio-protective, antioxidant and anti-carcinogenic effects while bringing support to sexual functions.
01 152827 1
Several herbs have been reported to stimulate, support and strengthen the sexual organs. For example, epimedium, cynomorri, cistanche, morindae, eucommia, cuscutae and cinnamon are reported to possess strengthening and stimulating properties which enhance sex drive.
Prescription erectile dysfunction products are based upon inhibiting an enzyme in the body called phosphodi-esterase (PDE-5). Under normal conditions sexual stimuli cause a local release of Nitrous Oxide (NO) which in turn stimulates a second messenger (cGMP) which dilates blood vessels in the penis leading to an erection. To turn off this signal PDE-5 breaks down the cGMP to terminate the action. By inhibiting this enzyme (PDE-5), prescription products prolong the effect of cGMP allowing more blood to flow into the caverns of the penis. Because other blood vessels of the body may be similarly affected, these products may be contraindicated for patients with the following underlying conditions:
* Patients who have suffered a Myocardial Infarction (heart attack), stroke, or life threatening arrhythmias
* Patients with resting hypotension (90/50) or hypertension (170/110)
* Patients with cardiac failure or Coronary Artery Disease (CAD)
* Patients with unstable angina
* Patients with retinitis
There is a need in the art to for natural products that can better promote energy and sexual health while avoiding some of the side effects of prescription pharmaceuticals.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide an herbal elixer helpful in promoting or maintaining energy.
01 152827.1
It is another object of the present invention to provide an herbal elixer helpful in promoting or maintaining sexual health.
In one embodiment, the invention provides an herbal supplement in the form of an aqueous elixer comprising extracts of at least three (and sometimes all four) agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum, morinda officinalis, and epimedium brevicornum.
In another embodiment, the invention provides an herbal supplement in the form of an aqueous elixer comprising extracts of at least four (and sometimes all five) agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum, morinda officinalis, panax ginseng and epimedium brevicornum.
In another embodiment, the invention provides an herbal supplement in the form of an aqueous elixer comprising extracts of epimedium brevicornum and of at least two additional agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum and morinda officinalis.
In some embodiments, each of the foregoing embodiments may further include extracts of at least two (and sometimes all three) agents selected from the group consisting of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
The multiple ingredients present in the formulations of the invention are expected to provide a focused synergistic effect on a man's sexual response and at the same time provide overall energy to sustain this response. The experience gathered over many years for most of the ingredients discussed herein creates an expectation of a good safety profile.
0U 52827. I
- A -
Other features and advantages of the present invention will become apparent from the following non-limiting description of preferred embodiments of the invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE INVENTION
In many preferred embodiments, extracts of epimedium are utilized. Without intending to be bound by theory, it is believed that epimedium provides benefits via modulation of Cortisol levels (a primary stress hormone). Under conditions of high physical stress, the increased Cortisol levels are believed to cause fatigue and depress sex drive. Thus, bringing Cortisol levels back into normal ranges is also believed to help restore normal metabolism, energy levels and libido.
According to traditional Chinese techniques, fortification of kidney energy and function may improve sexual stamina and performance while restoring vitality, energy and endurance. Some of the highly enriched ingredients of the present invention include agents which may be implicated in the maintenance of kidney health, thereby improving erections and strengthening and enhancing sexual functions in healthy males by a kidney-mediated mechanism, and may reduce symptoms for those who experience temporary or long term sexual dysfunction caused by stress, environmental or medical conditions.
The combination of Siberian Ginseng, Codonopsis and Red Ginseng, when used, is expected to provide the body with increased vitality and endurance important for sexual stamina. These longevity and energy herbs are believed to strengthen the system and be restorative to the body, helping to increase its efficiency. As a result they may help to direct more blood to the genitals and other erotically stimulated zones.
An example of an herbal extract in accordance with the invention, and of its method of manufacture is set forth below.
01 152827.1
EXAMPLE
A preferred all- natural herbal supplement of the invention is manufactured in a GMP compliant facility. Manufacturing begins by admixing the ingredients set forth below in the relative amounts set forth in the last column below. Thereafter the ingredients undergo extraction and preparation into an elixer in accordance with the technique set forth infra.
Ingredients Relative amount
Eucommia ulmoides 8
Cynomorium songaricum 8
Morinda officinalis 8
Panax ginseng 10
Epimedium brevicornum 8
Cinnamomum cassia 2
Cuscuta chinensis 6
Rehmannia glutinosa 8
Cordyceps sinensis 4
Lycium barbarum 4
Polygonum multiflorum 6
Schisandra chinensis 4
Achyranthes bidentata 6
Foeniculum vulgare 2
Bupleurum chinense 2
Ziziphus jujuba 2
Rhodiola rosea 6
01 152827 1
Extraction Process for the Production of the Elixir
Place the pre-mixed herb material (1 kg) in a round bottom flask of appropriate size, add 3 litres of 50% ethanol (the other 50% water). Carry out heated extraction under reflux for an additional 2 hours. Cool the content in the flask to room temperature and pour out the ethanol solution (Solution I). To the herb residue in the flask, add 2 litres of 50% ethanol and reflux for an additional 2 hours. Cool the content in the flask to room temperature and pour out the ethanol solution (Solution II). Combine Solutions I and II. Recover ethanol from the combined solution by distillation to reduce the volume of the solution to about 2.5 litres. Adjust the ethanol content to around 20% and the volume to 3.5 litres and stand at room temperature for 24 hours. Filter through cotton wool. Add 20% ethanol to the filtrate to make the final volume tol US Gallon (3.781itres). The solution is ready to be bottled.
Recommended daily dosage of the foregoing elixer is between 6 and 18 milliliters, e,g. about 10 milliliters.
Although the present invention has been described in relation to particular embodiments thereof, many other variations and modifications and other uses will become apparent to those skilled in the art. It is preferred, therefore, that the present invention be limited not by the specific disclosure herein, but only by the appended claims.
01152827 1
Claims
1. An herbal supplement in the form of an aqueous elixer comprising extracts of at least three agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum, morinda officinalis, and epimedium brevicornum.
2. An herbal supplement in the form of an aqueous elixer comprising extracts of at least four agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum, morinda officinalis panax ginseng and epimedium brevicornum.
3. An herbal supplement in the form of an aqueous elixer comprising extracts of epimedium brevicornum and of at least two additional agents selected from the group consisting of eucommia ulmoides, cynomorium songaricum and morinda officinalis.
4. The herbal supplement of claim 3 having extracts of each of eucommia ulmoides, cynomorium songaricum and morinda officinalis.
5. The herbal supplement of claim 1 further comprising extracts of at least two agents selected from the group consisting of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
6. The herbal supplement of claim 2 further comprising extracts of at least two agents selected from the group consisting of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
01152827 1
7. The herbal supplement of claim 3 further comprising extracts of at least two agents selected from the group consisting of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
8. The herbal supplement of claim 4 further comprising extracts of at least two agents selected from the group consisting of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
9. The herbal supplement of claim 1 further comprising extracts of each of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
10. The herbal supplement of claim 2 further comprising extracts of each of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
11. The herbal supplement of claim 3 further comprising extracts of each of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
12. The herbal supplement of claim 4 further comprising extracts of each of cinnamomum cassia, cordyceps sinensis and foeniculum vulgare.
01152827 1
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21881909P | 2009-06-19 | 2009-06-19 | |
US61/218,819 | 2009-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010148394A1 true WO2010148394A1 (en) | 2010-12-23 |
Family
ID=43356790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/039345 WO2010148394A1 (en) | 2009-06-19 | 2010-06-21 | Herbal supplement |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010148394A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102894014A (en) * | 2012-11-01 | 2013-01-30 | 彭万喜 | Method for preparing woody antibacterial agent |
CN103210847A (en) * | 2013-05-02 | 2013-07-24 | 甘肃凯源生物技术开发中心 | In-vitro embryo cultivation method for measuring vitality of cynomorium seeds |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020031559A1 (en) * | 2000-03-08 | 2002-03-14 | Liang Kin C. | Herbal suppositories |
US20030157208A1 (en) * | 2001-12-20 | 2003-08-21 | Rui Wang | Cynomoriaceae extract and use in treating erectile dysfunction |
US20040142001A1 (en) * | 2003-01-16 | 2004-07-22 | Kuok Koon Yong | Herbal compositions for prostate conditions |
US20040161524A1 (en) * | 2001-06-21 | 2004-08-19 | Yasushi Sakai | Process for producing a plant extract containing plant powder |
US20060210657A1 (en) * | 2001-07-17 | 2006-09-21 | Chou Wen H | Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
US20070041993A1 (en) * | 2003-05-29 | 2007-02-22 | Holcomb-Halstead Terri L | Compositions and methods for symptomatic relief |
US20070059386A1 (en) * | 2005-09-12 | 2007-03-15 | Tsun-Nin Lee | Modular system for novel Chinese herbal formulas |
US20070259058A1 (en) * | 2006-05-04 | 2007-11-08 | Rulin Xiu | Morinda herbal extracts and compositions thereof |
-
2010
- 2010-06-21 WO PCT/US2010/039345 patent/WO2010148394A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020031559A1 (en) * | 2000-03-08 | 2002-03-14 | Liang Kin C. | Herbal suppositories |
US20040161524A1 (en) * | 2001-06-21 | 2004-08-19 | Yasushi Sakai | Process for producing a plant extract containing plant powder |
US20060210657A1 (en) * | 2001-07-17 | 2006-09-21 | Chou Wen H | Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
US20030157208A1 (en) * | 2001-12-20 | 2003-08-21 | Rui Wang | Cynomoriaceae extract and use in treating erectile dysfunction |
US20040142001A1 (en) * | 2003-01-16 | 2004-07-22 | Kuok Koon Yong | Herbal compositions for prostate conditions |
US20070041993A1 (en) * | 2003-05-29 | 2007-02-22 | Holcomb-Halstead Terri L | Compositions and methods for symptomatic relief |
US20070059386A1 (en) * | 2005-09-12 | 2007-03-15 | Tsun-Nin Lee | Modular system for novel Chinese herbal formulas |
US20070259058A1 (en) * | 2006-05-04 | 2007-11-08 | Rulin Xiu | Morinda herbal extracts and compositions thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102894014A (en) * | 2012-11-01 | 2013-01-30 | 彭万喜 | Method for preparing woody antibacterial agent |
CN102894014B (en) * | 2012-11-01 | 2015-02-18 | 彭万喜 | Method for preparing woody antibacterial agent |
CN103210847A (en) * | 2013-05-02 | 2013-07-24 | 甘肃凯源生物技术开发中心 | In-vitro embryo cultivation method for measuring vitality of cynomorium seeds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101816739B (en) | Chinese medicinal composition and preparation method thereof | |
CN101062080B (en) | Medicinal composition for relieving fatigue and preparing process thereof | |
CN104666892A (en) | Sealwort and ginseng formula for enhancing immunity and relieving fatigue and preparation method of formula | |
CN103877263A (en) | Anti-fatigue health-prservation preparation prepared from composite traditional Chinese medicines including red ginseng, maca and green tea extract (theanine) | |
US20180028591A1 (en) | Male and female infertility herbal composition | |
CN112933203A (en) | Traditional Chinese medicine composition of medicinal liquor for resisting fatigue and improving sexual function and preparation method of traditional Chinese medicine composition | |
CN103251734B (en) | Traditional Chinese medicine health-care preparation with cistanche and acanthopanax as main medicines | |
Panossian et al. | Adaptogens in psychiatric practice | |
WO2010148394A1 (en) | Herbal supplement | |
CN1680533A (en) | Production of functional alcohol liquid | |
CN1593571A (en) | Chinese traditional medicine for treating hypertension | |
CN100558349C (en) | Ginseng-astragalus capsule formulation and preparation technology thereof | |
CN1730062A (en) | Chinese medicinal composition for invigorating spleen, tonifying kidney, relieving metal stress and its preparation process | |
CN1231248C (en) | Chinese medicine for reinforcing kidney and supporting yang | |
CN104306662A (en) | Traditional Chinese medicine composition for treating neurasthenia and preparation method thereof | |
CN101919924B (en) | Pharmaceutical composition for curing tristimania and preparation method and application thereof | |
CN1395956A (en) | Chinese medicine for treating depression and anxiety | |
CN100369622C (en) | Blood fat-reducing Chinese medicine and preparation method thereof | |
CN103705578A (en) | Traditional Chinese medicine preparation with functions of reducing blood fat and inhibiting blood glucose increase and preparation method thereof | |
CN108143800B (en) | Traditional Chinese medicine composition for treating hypertensive heart failure | |
CN103191258A (en) | Astragalus mongholicus and donkey-hide gelatin paste for treating chronic fatigue syndrome and production method thereof | |
CN109876127B (en) | Blood-nourishing angelica sinensis capsule and preparation method thereof | |
CN101912526A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
CN1218650C (en) | Health care tee for middle and old aged people | |
CN103301429B (en) | Oral preparation for treating women dysmenorrhea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10790322 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10790322 Country of ref document: EP Kind code of ref document: A1 |